Skip to main content
TipRanks
Go Ultimate75% OFF

Kimberlee C Drapkin Insider Profile

4 Followers

Kimberlee C Drapkin, Director at LENZ Therapeutics, holds ― shares in LENZ Therapeutics (Ticker: LENZ), holds 48.30K shares in Acumen Pharmaceuticals (Ticker: ABOS), holds 0.00 shares in Kineta (Ticker: KANT).

Kimberlee C Drapkin's Trading History

ABOS
Acumen Pharmaceuticals
Jun 05, 2026DirectorUninformative Buy―$11.11K
KANT
Kineta
Jul 02, 2025―Uninformative Sell―$0.00
JNCE
Jounce Therapeutics
May 04, 2023―Uninformative Sell―$0.00
CLYM
Climb Bio
―Director――
LENZ
LENZ Therapeutics
―Director――

You May Also Like

Kimberlee C Drapkin insider profile FAQ

What is the percentage of profitable transactions made by Kimberlee C Drapkin?
The percentage of profitable transactions made by Kimberlee C Drapkin is 60%.
What is the average return per transaction made by Kimberlee C Drapkin?
The average return per transaction made by Kimberlee C Drapkin is 11.50%.
What stocks does Kimberlee C Drapkin hold?
Kimberlee C Drapkin holds: LENZ, KANT, JNCE, ABOS, CLYM stocks.
What was Kimberlee C Drapkin's most profitable transaction?
Kimberlee C Drapkin’s most profitable transaction was an Informative Sell of JNCE stock on January 11, 2022. The return on the trade was 80.90%.
What is Kimberlee C Drapkin's role in LENZ Therapeutics?
Kimberlee C Drapkin's role in LENZ Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.